As of 2026-09-12, the EV/EBITDA ratio of Surface Oncology Inc (SURF) is -0.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SURF's latest enterprise value is 50.24 mil USD. SURF's TTM EBITDA according to its financial statements is -80.52 mil USD. Dividing these 2 quantities gives us the above SURF EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.3x - 8.9x | 8.0x |
| Forward P/E multiples | 6.8x - 12.1x | 7.8x |
| Fair Price | (9.45) - (11.54) | (10.28) |
| Upside | -982.8% - -1178.3% | -1060.7% |
| Date | EV/EBITDA |